Your browser is unsupported

We recommend using the latest version of IE11, Edge, Chrome, Firefox or Safari.

In this section

2019 Publications and Presentations by Dr. Sweiss

Here is the PubMed link for our 2018 publications:  
In addition to these the following manuscripts are online already and will be in PubMed soon:

Sweiss K, Calip GS, Wirth S, Rondelli D, Patel P.  Collaborative Physician-Pharmacist Managed Multiple Myeloma Clinic Decreases Polypharmacy, Improves Guideline Adherence, and Prevents Treatment Delays

Sweiss K, Calip GS, Johnson JJ, Jeong HY, Rondelli D, Patel P.  Pre-Transplant Hemoglobin and Creatinine Clearance Correlate with Treatment Free Survival in Patients with Myeloma Receiving Mel200 and Autologous Stem Cell Transplantation

Sweiss K, Calip GS, Lee J, Mahmud N, Rondelli D, Patel P.  A New Prognostic Score Using Lymphocyte to Monocyte Ratio and Immunoglobulin Levels to Predict Progression in Multiple Myeloma Patients Undergoing Autologous Transplant

Calip GS, Sweiss K, Adimadhyam S, Asfaw A, Zhou J, Wu Z, Lee TA, Chiu BC, Patel P.  Biologic disease-modifying antirheumatic drugs and risk of multiple myeloma

Calip GS, Zhou J, Sweiss K, Patel P, Asfaw A, Lee TA, Chiu BC, Nutescu E.  Venous thromboembolic prophylaxis following treatment initiation for multiple myeloma

Saraf S, Ghimire K, Patel P, Sweiss K, Quigley J, Khan I, Peace D, Gowhari M, Jain S, Galvin, Molokie R, Rondelli D.  Health Care Utilization in Transplanted Versus Non-Transplanted Sickle Cell Disease Patients.  Oral Abstract 

Christian S, Patel P, Agrawal V, Griffin S, Cahill K, Khan I, Sweiss K, Shergill A, Calip GS, Stock W, Odenike O, Konig H, Quigley J.  A Multi-Institution Comparison of Mitoxantrone, Etoposide and Cytarabine (MEC) Vs High-Dose Cytarabine and Mitoxantrone (Ara-C Couplets) Therapy for Patients with Relapsed or Refractory Acute Myeloid Leukemia

Lee I, Adimadhyam S, Nutescu, E, Sweiss K, Patel P, Calip GS. Arterial and Venous Thromboembolic Safety of Bevacizumab in Patients with High Grade Gliomas

Sweiss K, Calip GS, Oh AL, Rondelli D, Patel PR.Renal dysfunction within 90 days of FluBu4 predicts early and late mortality.Bone Marrow Transplant. 2018 Oct 19

Carnot Uria J, Hernández Cruz C, Muñío Perurena J, Torres Yribar W, Diego de la Campa J, Del Castillo Carrillo C, Rodríguez Fraga Y, López Silva JA, Cepero Llauger K, Pardo Ramírez IK, García García A, Sweiss K, Patel PR, Rondelli D.Bone Marrow Transplantation in Patients With Acute Leukemia In Cuba: Results From the Last 30 Years and New Opportunities Through International Collaboration.